KIDS Stock Gains From Its New Enabling Technologies Division Launch

Core Viewpoint - OrthoPediatrics Corp. has launched its Enabling Technologies division to address unmet pediatric needs in orthopedics, positioning the company at the forefront of pediatric digital health and enabling technologies sectors [1] Company Developments - The Enabling Technologies division is led by Kevin Unger and aims to differentiate OrthoPediatrics' core business, generate sustainable revenue growth, and access new markets beyond orthopedics [3] - The company has made significant advancements with the distribution of the 7D Flash Navigation System and a collaboration with 3D Side, S.A. for patient-specific cutting guides, laying a strong foundation for the new division [4] - OrthoPediatrics is set to launch two groundbreaking technology platforms: Playbook, a surgical workflow and outcome optimization platform, and Robotic-Assistance for Cochlear Implant Technology, in partnership with iotaMotion, Inc. [5][6] Recent Innovations - The company received the "Breakthrough Device" designation from the FDA for its eLLi surgical device, designed to address severe pathology associated with early onset scoliosis (EOS) [7] - Earlier this year, OrthoPediatrics launched the RESPONSE Rib and Pelvic Fixation system to treat children with EOS, marking its first solution for patients at risk of thoracic insufficiency syndrome [8] Industry Prospects - The global pediatric orthopedic devices market was valued at $3.83 billion in 2023 and is projected to grow at a CAGR of 11.0% from 2024 to 2030, driven by increased awareness of orthopedic conditions in children and innovations in device technology [9][10]